Recombinant Human POLg1 Protein，His

POLG1, or mitochondrial DNA polymerase gamma, is a crucial enzyme that plays a key role in the replication and maintenance of mitochondrial DNA (mtDNA). Mitochondria are the powerhouses of the cell, generating energy through oxidative phosphorylation, and their proper functioning is essential for cellular metabolism and overall health. Mutations in the POLG1 gene can lead to a variety of mitochondrial diseases characterized by energy deficiencies and a wide range of clinical manifestations, including neurodegenerative disorders, myopathies, and susceptibility to aging. The study of POLG1 recombinant proteins has gained traction as researchers seek to understand the molecular mechanisms underlying its enzymatic activity and the pathogenic effects of specific mutations. By producing and characterizing POLG1 recombinant proteins in vitro, scientists can elucidate the structure-function relationships of this enzyme, assess its fidelity and processivity in DNA synthesis, and explore potential therapeutic interventions. Additionally, the recombinant approach enables the study of POLG1 interactions with various cofactors and other mitochondrial proteins, further enriching our understanding of mitochondrial biology and the implications of POLG1 dysfunction in disease. As mitochondrial DNA plays a pivotal role in inherited metabolic disorders and age-related pathologies, POLG1 remains a significant focus in mitochondrial research, with the potential to lead to advancements in gene therapy and targeted treatments.